TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Arovella Therapeutics Limited ( (AU:ALA) ) has shared an update.
Arovella Therapeutics Limited announced a change in the director’s interest, with Debora Barton exercising options to acquire 1,013,333 ordinary shares while disposing of 1,386,667 unlisted options. This transaction, executed via a cashless exercise facility, reflects an adjustment in the director’s securities holdings, potentially impacting the company’s governance and shareholder dynamics.
More about Arovella Therapeutics Limited
Arovella Therapeutics Limited operates in the biotechnology industry, focusing on developing innovative therapies. The company’s primary products or services involve therapeutic solutions, potentially targeting specific medical conditions, with a market focus on enhancing treatment options.
Average Trading Volume: 1,415,469
Technical Sentiment Signal: Sell
Current Market Cap: A$106.7M
See more data about ALA stock on TipRanks’ Stock Analysis page.